Looking for AI and cancer research webinars? Explore the CAP-IT AI for Cancer Webinar Catalog — updated weekly with the latest webinar recordings, presentations, and resources. New entries have just been added! ncicapit.org/en/resources... #ArtificialIntelligence #AIinCancer #CancerPrevention

Congratulations to Dr. Yong Li on his appointment as the inaugural Director of Molecular Oncology & Cellular Therapeutics and the inaugural holder of the Paul and Linda DeBruce Endowed Chair in Cancer Immunotherapy at @childrensmercy.org! 🎉 news.childrensmercy.org/childrens-me...

At today’s #CAPITSCMeeting, Dr. Alan Hutson provided updates on the DRCC and the Bioinformatics WG. Dr. Margie Clapper shared progress from the Resource Sharing WG. Dr. Fenghuang Zhan of UAMS presented “Advances in CAR-T Immune Therapy: Targeting Tumor Cells and Environmental Cells in Myeloma.”

The June 2026 CAP-IT Newsletter is now live, featuring: 🔹 CAP-IT Summit highlights 🔹 Patient advocate panel discussion 🔹 U54 Center and DRCC progress updates 🔹 Recent network achievements and activities Read the full newsletter: indd.adobe.com/view/f35dd5b...

A great opportunity for anyone interested in mouse models of human cancer. This September, Workshop on Techniques in Modeling Human Cancer in Mice, at The Jackson Laboratory in Bar Harbor, Maine. www.jax.org/education-an...

We have built an AI for Cancer Webinar Catalog — a curated collection of artificial intelligence webinars gathered from publicly available sources across a wide range of academic, industry, and professional organizations. Explore the catalog here: ncicapit.org/en/resources...

Launched by the National Cancer Institute in 2021, Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) aims to develop a network for collaborative research in precision cancer prevention and interception. More info: t.ly/wlcI_ or ncicapit.org.

Some highlights from the just-concluded #CAPITSummit 🎉 www.linkedin.com/posts/nci-ca...

Back from the @ncicapit.org Summit! Honored to contribute to designing vaccines for cancer before it emerges. Advocates J. Ahlstrom @healthtreeorg.bsky.social, E. Krischner (Li-Fraumeni), & R. Dubin @aliveandkickn.bsky.social reminded us why this research matters #CancerPrevention #Lynchsyndrome

Postdoc Opportunity in Neoepitope-based Cancer Immune Interception! Join our @ncicapit.org research at @weillcornell.bsky.social to link immunoprevention targets with preclinical cancer preventive interventions. Apply by emailing [email protected]. #Postdoc #immunology #cancervaccines

Final call to register for the March 30 CAP-IT Summit! forms.gle/19GKAY6ADTXs... Don’t miss the opportunity to engage with leaders in cancer prevention and interception.

📣Faculty recruitment - cancer interception researcher at Fox Chase Cancer Center. See JD 👇

Only a few spots remaining! This is a great opportunity for early stage investigators to showcase their work to a broad scientific community. prevention.cancer.gov/funding-and-...

At today’s Bioinformatics & Computational Biology #CAPITWGMeeting, WG Chair Dr. Alan Hutson of @roswellpark.bsky.social k provided working group updates, and Dr. Li Zhang of Fox Chase Cancer Center presented on “Bayesian Compositional Models for Analyzing Microbiome Data.”

Dr. Yongfeng He, CAP-IT nvestigator in Dr. Vivek Mittal Lab at Weill Cornell Medicine, will present their vaccine research at the Major Symposium 5 " New Breakthroughs in TCR Engineering" at the AACR Immuno-Oncology Conference in Los Angeles. 🗓 Feb 20 | 9:30–11:00 AM PT www.aacr.org/meeting/aacr...

🧬 CIP-Net Project Spotlight UG3CA290454 is developing a preventive cancer vaccine for people with inherited BRCA1/2 mutations, using chimeric RNA-derived neoantigens to stop breast cancer before it forms. 👉Learn more on the CIP-Net website: www.nci-cipnet.org/en/members/u...

Join us at the CAP-IT Summit on March 30, 2026! The event is open to the public. ncicapit.org/en/cap-it-su...

Save the date! The #CAPITSummit is happening on March 30, 2026. A full day of science, strategy, and community—bringing together researchers, clinicians, and advocates to advance cancer prevention and interception. Register now and join us: tinyurl.com/5c6snwyz

Save the date! The hashtag#CAPITSummit is happening on March 30, 2026. A full day of science, strategy, and community - bringing together researchers, clinicians, and advocates to advance cancer prevention and interception. Register now and join us: tinyurl.com/5c6snwyz

Rewiring natural killer cells for next-generation cancer therapies

At today’s #CAPIT Bioinformatics & Computational Biology WG meeting, Dr. Chi Zhang of University of Nebraska - Lincoln presented his work on AI-powered image feature extraction and data synthesis in pancreatic cancer.

The latest CAP-IT Newsletter is out! It features highlights and reports from the July 2025 CAP-IT Summit, along with updates on network progress: indd.adobe.com/view/32541c2...

New Tools and Resources from the NCI Data Sharing Hub , now added to the CAP-IT Shared Resources Catalog. Check it out and all NCI/NIH Shared resources at the link below: ncicapit.org/en/resources...

The amazing @ptorresayuso.bsky.social from #FoxChaseCancerCenter and #TempleUniversity presenting his exciting research at the @ncicapit.bsky.social summit

The 2025 Annual @ncicapit.bsky.social Summit is #Outofthisworld good!!! The plenary speaker #EvaSzabo, the keynote presentation by #RafiAhmed followed by AI guru #ChanghueiYang & #force ‘s #SueFredman & panelist for #EmergingTechnologies lead by the amazing #ShannonHughes were extraordinary!!!

Don't wait - register now for the CAP-IT Virtual Annual Summit on July 24, 2025! Open to the public with exciting talks on cancer prevention and interception. 🔗 Register: tinyurl.run/M3wsBV ℹ️ Info: ncicapit.org 📧 [email protected] #CancerPrevention #NCICAPIT

A personalized neoantigen vaccine + Montanide/poly-ICLC/ipilimumab reshapes the T cell landscape in melanoma patients: - Strong CD8+ responses - TCR repertoires expanded beyond anti–PD-1 - Vaccine-specific TILs identified post-treatment www.cell.com/cell/abstrac...? #Neoantigen #Melanoma #Tcells

We have a great lineup of events this summer, we hope you can join us!

New in @cellcellpress.bsky.social : Exercise boosts immune checkpoint inhibitor (ICI) efficacy in #Melanoma via microbiota-derived formate, which enhances CD8⁺ T cell immunity through Nrf2 activation. cell.com/cell/abstrac... #Immunotherapy #Microbiome #CancerResearch

Now online!

New in @thelancet.com : A comprehensive review on cancer vaccines and their role in shaping the future of immunotherapy. Read here: www.thelancet.com/journals/lan...

New @thelancet.com - Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial www.thelancet.com/journals/lan... #GastroSky #MedSky #OncSky

New study in Cell: HIF upregulates endogenous retroviruses in clear cell kidney cancer, generating tumor-specific antigens. ERV-targeting T cells show promise for immunotherapy and HIF stabilizers may unlock similar responses in other tumors. #CAPITPublication pubmed.ncbi.nlm.nih.gov/40023154/

We’re excited to announce that the CAP-IT Virtual Annual Summit will be held on July 24, 2025! Register here: docs.google.com/forms/d/e/1F... For more information, visit : ncicapit.org or email: [email protected] #CancerPrevention #NCICAPIT

REVIEW 🚨 Cancer prevention vaccines have reduced cancer-related mortalities, yet therapeutic cancer vaccine development + clinical translation continue to face challenges. Here, Zaidi, Jaffee & Yarchoan summarize this & highlight advances in the field. 📖 👇

NEW content online!

Small-molecule RNA therapeutics to target prostate cancer

Translation dysregulation in cancer as a source for targetable antigens

Online Now: Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

🚨 The 2025 #CAPITSummit is coming! 🗓️ Agenda is live & public registration is now open! 🔗 Explore the program & sign up today via the CAP-IT web portal: ncicapit.org/en/cap-it-su...

May is Brain Tumor Awareness Month. Here's what you should know about the brain and brain tumors.

We’re excited to announce that the CAP-IT Virtual Annual Summit will be held on July 24, 2025! Register here by May 16, 2025: docs.google.com/forms/d/e/1F... For more information please visit : NCICAPIT.org or email: [email protected] #CancerPrevention #NCICAPIT

🚨 New #JITC article: Researchers uncover frameshift-derived neopeptides in Lynch syndrome—opening doors to innovative cancer prevention strategies. 🔬 Read more: bit.ly/3EiJBUN

Sometimes cancer returns years after treatment—often having spread. Researchers suspect dormant cancer cells and their interactions with the immune system play a key role in when and how this happens. www.cancer.gov/news-events/...

Colon cancer is on the rise around the world. This new report concludes that early-life exposure to gut bacteria that produces colibactin, which is mutagenic, may be contributing www.nature.com/articles/s41...

Data demonstrated that MyD88 acts downstream of the T-cell receptor to regulate T cell fate implying a molecular mechanism for #MyD88 in T cell biology that could be targeted to fine-tune T cell effector function and survival therapeutically. Read more: ow.ly/yPEs50VGr17

📢ONLINE @naturegenet.bsky.social 📰Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring. By Wenbao Yu, Kai Tan and colleagues. ⬇️ www.nature.com/articles/s41...

A new treatment approach for advanced-stage Hodgkin lymphoma is showing promising results. “This treatment appears to be more effective and less toxic — and really sets a new standard,” says Margaret Shipp, MD. Learn more: bit.ly/4cBH98f